Oxidative stress in cardiovascular disease

Journal of Nuclear Cardiology

Volumn 8, Issue 3, 2001, Pages 379-389

  Parthasarathy, Sampath ^a   Khan Merchant, Nadya ^a   Penumetcha, Meera ^a   Santanam, Nalini ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; ANTIOXIDANT; ARGININE; ASCORBIC ACID; BETA CAROTENE; CARVEDILOL; CURCUMIN; ESTROGEN; FISH OIL; PHENOL DERIVATIVE; PHENYLENEDIAMINE DERIVATIVE; POLYUNSATURATED FATTY ACID; PROBUCOL; PROGESTERONE; SELENIUM; VITAMIN;

AEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY; ARTICLE; ATHEROGENESIS; BEHAVIOR MODIFICATION; CARDIOVASCULAR DISEASE; CELL CULTURE; CONTROLLED STUDY; DIET; DRUG CHOICE; DRUG DOSE; ENZYME INDUCTION; EXERCISE; EXPERIMENTAL MODEL; HUMAN; HYPOTHESIS; IN VIVO STUDY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIMATE; PRIORITY JOURNAL; PROTECTION; RABBIT;

EID: 0034974433     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2001.114150     Document Type: Article

References (64)

1. Degradation of apolipoprotein B-100 in human chylomicrons
2. Modulation of endotoxin-induced endothelial cell toxicity by low density lipoprotein
3. Injury to cultured endothelial cells induced by low density lipoproteins: Protection by high density lipoproteins
4. Enhanced macrophage degradation of biologically modified low density lipoprotein
5. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
6. Oxidants and antioxidants in atherogenesis-an appraisal
7. 7 beta-Hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein
8. Characterization of endothelial cell injury by cholesterol oxidation products found in oxidized LDL
9. Why are low-density lipoproteins atherogenic?
10. Oxidized low density lipoprotein induces activation of the transcription factor NF kappa B in fibroblasts, endothelial and smooth muscle cells
11. Oxidized low density lipoprotein suppresses activation of NF kappa B in macrophages via a pertussis toxin-sensitive signaling mechanism
12. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells
13. Differentiation of binding sites on reconstituted hepatic scavenger receptors using oxidized low-density lipoprotein
14. Electronegative LDL from normolipemic subjects induces IL-8 and monocyte chemotactic protein secretion by human endothelial cells
15. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells
16. Regulation of endothelial nitric oxide synthase gene expression by oxidized linoleic acid
17. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis
18. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta
19. Modulation of expression of endothelial nitric oxide synthase by nordihydroguaiaretic acid, a phenolic antioxidant in cultured endothelial cells
20. Oxidants induce transcriptional activation of manganese superoxide dismutase in glomerular cells
21. Induction of mitochondrial manganese superoxide dismutase in macrophages by oxidized LDL: Its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits
22. Induction of haem oxygenase as a defence against oxidative stress
23. Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL
24. Lipid peroxides induce expression of catalase in cultured vascular cells
25. Treatment of macrophages with oxidized low-density lipoprotein increases their intracellular glutathione content
26. Shear stress enhances glutathione peroxidase expression in endothelial cells
27. Estradiol as an antioxidant: Incompatible with its physiological concentrations and function
28. Does acute exercise affect the susceptibility of low density lipoprotein to oxidation?
29. Exercise and cardiovascular disease: A new perspective
30. Potential role of oxidized lipids and lipoproteins in antioxidant defense
31. Glucose oxidation and replacement during prolonged exercise in man
32. Endotoxaemia, production of tumour necrosis factor alpha and polymorphonuclear neutrophil activation following strenuous exercise in humans
33. Capacity of circulating neutrophils to produce reactive oxygen species after exhaustive exercise
34. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells
35. Estrogens as antioxidants
36. Estrogen binding by leukocytes during phagocytosis
37. Antioxidant activities of estrogens against aqueous and lipophilic radicals: Differences between phenol and catechol estrogens
38. Low density lipoprotein rich in oleic acid is protected against oxidative modification: Implications for dietary prevention of atherosclerosis
39. The influence of cod-liver oil diet on various lipid metabolism parameters, the thromboxane formation capacity, platelet function and the serum MDA level in patients suffering from myocardial infarction
40. Oxidizability and subsequent cytotoxicity of chylomicrons to monocytic U937 and endothelial cells are dependent on dietary fatty acid composition
41. The fatty acid composition of human gliomas differs from that found in nonmalignant brain tissue
42. Effects of lipid-lowering diets enriched with monounsaturated and polyunsaturated fatty acids on serum lipoprotein composition in patients with hyperlipoproteinaemia
43. Dietary polyunsaturated fat decreases coronary artery atherosclerosis in a pediatric-aged population of African green monkeys
44. Dietary monounsaturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human ApoB100-overexpressing transgenic mice
45. A comparison of the kinetics of low-density lipoprotein oxidation initiated by copper or by azobis (2-amidinopropane)
46. Stimulated arachidonate metabolism during foam cell transformation of mouse peritoneal macrophages with oxidized low density lipoprotein
47. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism vasculopathy of diabetes
48. Prevention of the hyperlipidemic serum or LDL-induced cellular cholesterol ester accumulation by 22-hydroxy-cholesterol and its analogue
49. Vitamin E supplementation and cardiovascular events in high-risk patients
50. The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardio (GISSI)-Prevenzione Trial on fish oil and vitamin E supplementation in myocardial infarction survivors
51. Multivitamin use and mortality in a large prospective study
52. Vitamin E treatment of patients with coronary disease (Cambridge Heart Antioxidant Study-CHAOS)
53. Effects of alpha tocopherol and beta carotene supplements on symptoms, progression, and prognosis of angina pectoris
54. Tissue damage in acute myocardial infarction: Selective protection by vitamin E
55. Dietary antioxidants and risk of myocardial infarction in the elderly: The Rotterdam study
56. Coronary heart disease in smokers: Vitamin C restores coronary microcirculatory function
57. Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: Possible role of reactive oxygen species
58. Insulin resistance and endothelial dysfunction in smokers: Effects of vitamin C
59. Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering
60. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease
61. Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men
62. The effect of long-term probucol intake on the lipoprotein cholesterol content and glutathione peroxidase activity in the blood of patients with coronary arteriosclerosis and hyperlipidemia
63. Effect of postmenopausal hormone therapy on lipoprotein(a) concentration
64. Is hormone replacement therapy cardioprotective? Decision-making after the heart and estrogen/progestin replacement study